Trajectories of brain loss in aging and the development of cognitive impairment

N E Carlson1, M M Moore, A Dame

  • 1Division of Biostatistics, Department of Public Health and Preventive Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd., Mail Code CB669 Portland, OR 97239, USA carlsoni@ohsu.edu

Neurology
|November 30, 2007
PubMed
Abstract

Insights

Brain volume loss accelerates years before mild cognitive impairment (MCI) diagnosis. This accelerated ventricular expansion, particularly 24 months prior to symptoms, offers potential windows for future dementia prevention therapies.

Area of Science:

  • Neuroimaging
  • Gerontology
  • Neurology

Background:

  • Volumetric MRI is a presumed biomarker for dementia transitions.
  • Rapid brain volume loss is thought to mark the shift from normal aging to mild cognitive impairment (MCI).
  • The precise trajectory of volume loss relative to clinical transition timing remains unestablished.

Purpose of the Study:

  • To establish the trajectory of brain volume loss in relation to the clinical transition to dementia.
  • To compare brain volume loss patterns in healthy aging versus those who develop MCI.

Main Methods:

  • Annual clinical and volumetric brain MRI assessments of ventricular volume in 79 healthy elderly subjects over 15 years.
  • 37 subjects developed MCI during the study.
  • A mixed-effects model with a change point analyzed brain volume loss patterns.

Main Results:

  • Brain loss trajectories differed between healthy aging and subjects who developed MCI.
  • Annual ventricular expansion rates were higher in those who later developed MCI.
  • Ventricular expansion accelerated approximately 2.3 years before MCI clinical diagnosis.

Conclusions:

  • Ventricular expansion is notably faster in individuals who develop MCI, preceding clinical symptoms by years.
  • A significant acceleration in ventricular expansion occurs around 24 months before symptom onset.
  • These preclinical atrophy rates indicate potential windows for future dementia prevention interventions.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.